Keys to off-label communications
The TGA and the Medicines Australia Code of Conduct are very clear on the appropriateness and dissemination of off-label information to…
Hot Topics
Is our product a medicine, a device, a cosmetic, an OTG or a food… and what could it be?
An increasing number of traditionally pharma/device companies are crossing boundaries to offer their patients a product portfolio spanning several product categories….
Using an overseas reference product in your bioequivalence studies
In order to consider whether this process is possible, the TGA have a list of exclusion criteria regarding the use this…
Release for supply – What every sponsor should know
Every batch of medicine sold or supplied in Australia is required to have undergone a “release for supply”…
5 reasons to call in the experts: Establishing a pharma business in Australia
Commercial Eyes has assisted a number of companies to establish a pharma business in Australia, so what are 5 reasons to call in the…
Medical Information by instant message
1800 numbers and written responses such as letters and emails are a well-established part of all Medical Information services. However consumers and healthcare professionals are increasingly tech-savvy….
A PV database to meet your needs… and your budget
Just as medicines and medical devices are held to stringent quality controls, so too is the software used to support the safety and efficacy of those same medicines and medical…
Innovation in Healthcare: Aligning clinical development and commercial strategies
From penicillin to the human genome, innovation can generate great leaps in…
Commercial Eyes helping to break the cycle of poverty
Andrew Carter, our Managing Director, was fortunate to be able to spend some time with Tara Winkler, Founder and Director of the Cambodian Children’s Trust (CCT), on her recent visit…